期刊文献+

消化系统恶性肿瘤患者细胞免疫功能分析及其临床意义 被引量:9

Clinical significance and analysis of cellular immunity functional on patients with digestive system malignant tumor
下载PDF
导出
摘要 目的:检验消化系统恶性肿瘤患者外周血T淋巴细胞亚群,了解细胞免疫功能状态及其变化。方法:用实用McAb-A-E直接法检验消化系统恶性肿瘤患者72例及37例健康正常对照组的外周血抗凝血CD3+、CD4+、CD8+及CD4+/CD8+指标。并将恶性肿瘤组与健康正常对照组进行比较。结果:恶性肿瘤组CD3(+%)、CD4(+%)、CD8(+%)和CD4+/CD8+分别为:63.88±14.26、34.44±12.14、37.42±10.01和0.96±0.38;健康对照组分别为:69.24±9.46、44.41±5.96、33.30±4.38和1.35±0.20。恶性肿瘤组与健康对照组、正常值CD3+、CD4+、CD8+和CD4+/CD8+相比,恶性肿瘤组(食道癌、胃癌、肝癌、肠癌)CD3+和CD4+细胞阳性率和CD4+/CD8+比值均降低,CD8+细胞阳性率增高,方差分析结果均P<0.05和0.01,有统计学意义。结论:消化系统恶性肿瘤患者的CD3+、CD4+细胞阳性率和CD4+/CD8+比值均降低,CD8+细胞阳性率增高,说明消化系统恶性肿瘤患者的细胞免疫功能处于抑制状态。 Objective:To detect T lymphocyte phenotype in peripheral blood of patients with digestive system malignant tumor in order to understand the change of cellular immunity function condition. Methods: T lymphocyte phenotype in peripheral blood from 72 cases of digestive system malignant tumor and 37 healthy controls were deteced by direct practically McAb-A-E in which results in two groups were compared. Results: CD3+(%),CD4+(%),CD8+(%) and CD4+/CD8+ ratio in the digestive system malignant tumor group was respectively 63.88±14.26,34.44±12.14,37.42±10.01 and 0.96±0.38,and in the healthy control group was respectively 69.24±9.46,44.41±5.96,33.30±4.38 and 1.35±0.20.CD3+,CD4+ and CD4+/CD8+ ratio in the digestive system malignant tumor group was lower than that in the healthy control group(P0.05).CD8+ in the digestive system malignant tumor group was increase than that in the healthy control group(P0.01). Conclusion: The immunity function of the digestive system malignant tumor is low and the inhibitory state.
出处 《甘肃医药》 2011年第5期259-261,共3页 Gansu Medical Journal
基金 甘肃省自然科学研究基金计划资助项目(1010RJZA144)
关键词 消化系统恶性肿瘤 T淋巴细胞亚群 细胞免疫功能 检验 digestive system malignant tumor T lymphocyte phenotype cellular immunity function condition detection
  • 相关文献

参考文献6

二级参考文献16

  • 1李小荣,杨连粤,贺志军.大肠癌患者手术前后细胞免疫变化的初步研究[J].中国现代医学杂志,1996,6(4):15-16. 被引量:1
  • 2[1]Wang XY, Kazim L. Immunization with tumor-derived ER chaperone grp170 elicits tumor- specific CD-8+ T-cell responses and reduces pulmonary metaststic disease[J]. Int J Cancer,2003,105(2):226-231.
  • 3[2]Oleinik EK, Oleinik VM. Phenotype of peripheral blood lymphocytes in patients with lung cancer[J]. Voper Onkol,2001, 47(4);436-439.
  • 4[3]Peng L, Kjaergaard J, Plautz GE. Helper-independent, Lselectinlow CD+8 T cells with broad anti-tumor efficacy are naturally sensitized during tumor progression[J]. J Immunol, 2000,165(100):5738-5749.
  • 5[4]Woo EY, Chu CS. Regulatory CD4(+)CD(25)T cells in tumors from patients with early-stage non-small cell lung cancer and late stage ovarian cancer[J]. Cancer Res,2001,61(12):4766-4772.
  • 6[5]Kenndy RC, Shearer MH. CD4+ T lymphocyte play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen [J]. Cancer Res, 2000, 63(5):1040-1045.
  • 7[3]Lissoni P, Brivio F,Ferrante R,et al. Circulating immature and mature dendritic cells in relation to lymphocyte subsets in patients with gastrointestinal tract cancer [J].Int J Biol Markers.2000,15(1):22-25.
  • 8[4]Robinson E,Segal R,Struminger L,et al. Lymphocyte subpopulations in patients with multiple primary tumors [J].Cancer, 1999,85(9):2073 -2076.
  • 9Ben-Efraim S.One hundred years of cancer immunotherapy: a critical appraisal. Tumor Biol, 1999,20:1-24.
  • 10汪明春,杨力建,郭秀枝,陈少华.组胺H_2受体阻滞剂对再生障碍性贫血患者CD_8^+细胞抑制正常BFU-E生长的影响[J].中华血液学杂志,1999,20(10):535-536. 被引量:7

共引文献17

同被引文献81

引证文献9

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部